Fairmount Funds Management LLC
- SEC CIK
- 0001802528
- Latest filing
- Aug 14, 2026
Holdings in Q2 2026
Holdings as of Jun 30, 2026, filed Aug 14, 2026. Long positions only; changes compare share counts with Q1 2026.
- Positions
- 12
- 0 vs. Q1 2026
- Portfolio value
- $1.51B
- +$128.6M (+9.3%) vs. Q1 2026
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| ORKAOruka Therapeutics, Inc. | COM | 3,705,262 | $352.6M | 23.3% | 00.0% | Unchanged | History |
| DNTHDianthus Therapeutics, Inc. | COM | 2,537,191 | $247.3M | 16.3% | 00.0% | Unchanged | History |
| DMRADamora Therapeutics, Inc. | COM NEW | 8,713,000 | $226.6M | 15.0% | 00.0% | Unchanged | History |
| COGTCogent Biosciences, Inc. | COM | 5,503,418 | $213.0M | 14.1% | 00.0% | Unchanged | History |
| JBIOJade Biosciences, Inc. | COM NEW | 4,553,494 | $101.2M | 6.7% | 00.0% | Unchanged | History |
| ELVNEnliven Therapeutics, Inc. | COM | 1,855,644 | $94.2M | 6.2% | 00.0% | Unchanged | History |
| VRDNViridian Therapeutics, Inc. | COM | 5,090,928 | $93.5M | 6.2% | +1,176,470+30.1% | Added | History |
| ZBIOZenas BioPharma, Inc. | COM | 2,359,025 | $59.9M | 4.0% | 00.0% | Unchanged | History |
| CBIOCrescent Biopharma, Inc. | COM | 2,747,866 | $49.5M | 3.3% | 00.0% | Unchanged | History |
| APGEApogee Therapeutics, Inc. | COM | 298,647 | $39.6M | 2.6% | 00.0% | Unchanged | History |
| FTHFaeth Therapeutics, Inc. | COM NEW | 722,020 | $18.1M | 1.2% | +722,020 | New | History |
| IKTInhibikase Therapeutics, Inc. | COM NEW | 8,625,000 | $17.5M | 1.2% | 00.0% | Unchanged | History |
Sold out since Q1 2026 (1)
Positions held at the end of Q1 2026 that are gone from this filing.